1. Home
  2. SCLX vs ACU Comparison

SCLX vs ACU Comparison

Compare SCLX & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$19.15

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$37.07

Market Cap

145.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
ACU
Founded
2011
1867
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
139.3M
145.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
ACU
Price
$19.15
$37.07
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
122.8K
9.4K
Earning Date
11-14-2025
10-21-2025
Dividend Yield
N/A
1.73%
EPS Growth
N/A
N/A
EPS
N/A
2.45
Revenue
$40,360,000.00
$194,960,991.00
Revenue This Year
N/A
$3.05
Revenue Next Year
$749.70
$4.20
P/E Ratio
N/A
$15.13
Revenue Growth
N/A
2.35
52 Week Low
$3.60
$34.35
52 Week High
$34.27
$45.25

Technical Indicators

Market Signals
Indicator
SCLX
ACU
Relative Strength Index (RSI) 51.13 47.72
Support Level $18.34 $36.24
Resistance Level $20.62 $38.16
Average True Range (ATR) 2.22 0.85
MACD -0.02 0.21
Stochastic Oscillator 32.91 59.02

Price Performance

Historical Comparison
SCLX
ACU

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: